According to Insmed's latest financial reports the company's current EPS (TTM) is -$5.27. In 2022 the company made an earnings per share (EPS) of -$3.90 a decrease over its 2021 EPS that were of -$3.87.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$5.27 | 35.13% |
2022 | -$3.90 | 0.78% |
2021 | -$3.87 | 28.57% |
2020 | -$3.01 | -0.99% |
2019 | -$3.04 | -27.96% |
2018 | -$4.22 | 47.55% |
2017 | -$2.86 | 0.7% |
2016 | -$2.84 | 39.9% |
2015 | -$2.03 | 9.73% |
2014 | -$1.85 | 17.09% |
2013 | -$1.58 | 0.64% |
2012 | -$1.57 | -46.42% |
2011 | -$2.93 | 497.96% |
2010 | -$0.49 | -105.1% |
2009 | $9.61 | -850.78% |
2008 | -$1.28 | -24.71% |
2007 | -$1.70 | -71.67% |
2006 | -$6.00 | -28.57% |
2005 | -$8.40 | 23.53% |
2004 | -$6.80 | 134.48% |
2003 | -$2.90 | -73.64% |
2002 | -$11.00 | -2.65% |
2001 | -$11.30 | -86.64% |
2000 | -$84.61 |